Wall St closes lower on vaccine delay, dampened stimulus hopes

Johnson & Johnson announced on Monday it was pausing clinical trials of a COVID-19 vaccine candidate due to an unexplained illness in a study participant. The delay weighed on the company's shares, even after its beat-and-raise earnings report. Its shares lost 2.3%.

from Stocks-Markets-Economic Times https://ift.tt/314f71Y

Related Posts:

0 Comments:

Post a Comment